This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

Advances in Heart Failure Pharmacotherapy

Advances in Heart Failure Pharmacotherapy

Format

Webcast

Time to Complete

1 hour

Released

February 8, 2017

Expires

February 8, 2018
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / CE for Pharmacists (0.10 CEUs)

Accredited Provider

This activity is provided by The Cleveland Clinic Foundation Center for Continuing Education.

Commercial Supporter

The Cleveland Clinic Foundation Center for Continuing Education acknowledges an educational grant for support of this activity from Novartis Pharmaceuticals Corporation.

Program Description

The interactive Webinar “Advances in Heart Failure Pharmacotherapy” is based on a videotaped “Tall Rounds” didactic presentation of the same name held at the Heart and Vascular Institute of the Cleveland Clinic on November 2, 2016. The “Tall Rounds” expert faculty discusses heart failure agents and recommendations for their use, as described in the 2013 American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) Guideline for the Management of Heart Failure. Topics include conventional drug classes, such as angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), beta blockers, diuretics, and aldosterone antagonists; the role of new and emerging agents with novel mechanisms of action; safety and efficacy data of new agents, based on clinical trials; and the potential role of new agents in practice. Discussion concludes with a look at how a multidisciplinary team approach to management can benefit patients with chronic heart failure.

Table of Contents

Introduction
When to Consider Aldosterone Receptor Antagonists
When to Consider Sacubitril/Valsartan
When to Consider Ivabradine
Adverse Effects, Dose Titration and Contraindications
Panel Discussion & Questions

Intended Audience

This activity has been designed to address the educational needs of physicians and pharmacists. It may also be of benefit to other healthcare providers such as PAs, nurse practitioners, and other healthcare professionals who make up the multidisciplinary team responsible for the treatment of patients with chronic heart failure.

Educational Objectives

Upon proper completion of this activity, participants should be better able to:

  • Summarize recommendations for pharmacologic treatment of chronic heart failure according to current clinical data and the 2013 ACCF/AHA Guideline for the Management of Heart Failure
  • Describe the mechanisms of action of, clinical evidence for, and appropriate use of newer chronic heart failure therapies
  • Explain the benefits of a multidisciplinary team approach to treating patients with chronic heart failure, using examples of potential collaboration among healthcare practitioners

Conflict Of Interest Disclosure Policy

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

Faculty

W. H. Wilson Tang, MD (Chair)
Director
Center for Clinical Genomics
Research Director and Staff Cardiologist
Section of Heart Failure and Cardiac Transplantation Medicine
Cleveland Clinic
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Cleveland, OH

Dr. Tang has no financial relationships to disclose.

Nancy M. Albert, PhD, CCNS, CHFN, CCRN, NE-BC, FAHA, FCCM, FAAN
Associate Chief Nursing Officer
Office of Nursing Research and Innovation
Cleveland Clinic Health System
Clinical Nurse Specialist
Kaufman Center for Heart Failure
Heart and Vascular Institute
Cleveland Clinic
Cleveland, OH

Dr. Albert has the following financial relationships to disclose:
Consulting: Novartis Pharmaceuticals Corporation
Teaching/Speaking: Amgen Inc.; Novartis Pharmaceuticals Corporation

Eiran Z. Gorodeski, MD, MPH
Director
Center for Connected Care
Staff Cardiologist
Section of Heart Failure and Cardiac Transplantation Medicine
Cleveland Clinic
Assistant Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Cleveland, OH

Dr. Gorodeski has the following financial relationships to disclose:
Consulting: Novartis Pharmaceuticals Corporation

Antonio L. Perez, MD
Fellow, Advanced Heart Failure and Transplant Cardiology
Cleveland Clinic
Cleveland, OH

Dr. Perez has no financial relationships to disclose.

J. Bradley Williams, PharmD, BCPS
Heart Failure/Heart Transplant Clinical Pharmacy Specialist
Department of Pharmacy
Cleveland Clinic
Cleveland, OH

Dr. Williams has no financial relationships to disclose.

Activity Director:
Katherine J. Hoercher, RN, FAHA

Senior Director
Heart and Vascular Institute
Director
Kaufman Center for Heart Failure
Director of CME Education
Heart and Vascular Institute
Clinical Lead Care Paths and Bundles
Cleveland Clinic
Cleveland, OH

Accredited Provider Disclosure

All other planners, CME staff, and content reviewers, have no relevant financial relationships to disclose.

Katherine J. Hoercher, RN, FAHA, has no financial relationships to disclose.
Amanda Glazar, PhD, has no financial relationships to disclose.
Laura Gilsdorf has no financial relationships to disclose.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Credit

1.00

Type

CE for Pharmacists

Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Designation Statement

Global Education Group designates this continuing education activity for 1.00 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number – 0530-9999-16-415-H01-P)

This is a knowledge-based activity.

This activity is provided by Global Education Group.



For information about the pharmacy accreditation of this program, please contact Global at (303) 395-1782 or inquire@globaleducationgroup.com.

Additional Credit Information

PA Continuing Education
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM   from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.00 Category 1 credits for completing this activity.

Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM   from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Instructions

To receive a CE certificate of participation, you should:

  • Follow the "Start Activity" button to go to the Paradigm Medical Communications website, where you will complete the pretest.
  • View the online activity in its entirety.
  • Complete and submit the online post-test and evaluation. You must answer 70% of the post-test questions correctly to earn credit. You will have unlimited opportunities to successfully complete the post-test.
A certificate of participation will be available for download/printing immediately following your successful completion of the post-test and evaluation. Your certificate will be saved on the Paradigm Medical Communications website and will not be available in your myCME CME History.

Please note: To claim CPE credit, please make sure you include your date of birth and NABP number. All credit information will be uploaded into CPE Monitor within 30 days.

There is no fee required for participation in this activity.

For questions regarding CE credit, contact the Paradigm CME Department at (845) 398-5949.

Technical Support: If you have any technical problems or playback issues, please email Paradigm at contactus@paradigmmc.com.

Privacy Policy

The Cleveland Clinic Foundation, Global Education Group and Paradigm Medical Communications, LLC are committed to protecting the privacy of those who participate in the activities (herein referred to as “website") located at www.paradigmmc.com. The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.

Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.

Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by the Cleveland Clinic Foundation, Global Education Group and Paradigm Medical Communications, LLC to continuously improve the learning experience.

The Cleveland Clinic Foundation, Global Education Group and Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. The Cleveland Clinic Foundation, Global Education Group and Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. The Cleveland Clinic Foundation, Global Education Group and Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.

myCME privacy policy

System Requirements

This certified CE activity is designed using HTML5 video.

For Desktops (Windows/Mac)
Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher

For Tablets (iPad/Android/Surface)
iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher

Copyright

Copyright© 2017 The Cleveland Clinic Foundation. All Rights Reserved.
Add to Queue